Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPEVAX followed by REVAXIS booster immunization study in adults aged 40 years or older
2010-023086-21Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Adacel Polio and diphtheria toxoid adsorbed + tetanus toxoid adsorbed in diphtheria, Tetanus, poliomyelitis and 1 more, sponsored by Sanofi Pasteur MSD S.N.C. Primary endpoint: Seroprotection rate after dose 3. Started Oct 2010; status: completed.
02
Drugs
Adacel Poliodiphtheria toxoid adsorbed + tetanus toxoid adsorbed
03
Conditions
diphtheriaTetanuspoliomyelitispertussis
Beyond the preview
Go deeper on 2010-023086-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023086-21.